Read about Enteris BioPharma oral drug delivery news and innovation via press releases, press coverage, & upcoming events.
- Peptelligence® Technology enables oral delivery of peptides and expands patient access A clinical-stage biopharmaceutical company focused on peptide therapies for the treatment of several unmet medical needs recognized that developing its lead asset solely as an injectable would ultimately limit the drug’s market penetration and patient acceptance.
- Differentiate
By Being Specific The recent trend towards the “one-stop-shop” CMO that provide services from development to commercialization may not be all it’s chalked up to be. Particularly with large molecule drugs, it is becoming apparent that the best way to differentiate in the world of CMOs is to differentiate, by being specific.
